APA (7th ed.) Citation

Shariati, A., Dadashi, M., Chegini, Z., van Belkum, A., Mirzaii, M., Khoramrooz, S. S., & Darban-Sarokhalil, D. (2020). The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: A systematic review and meta-analysis. Antimicrobial resistance & infection control, 9(1), 56-20. https://doi.org/10.1186/s13756-020-00714-9

Chicago Style (17th ed.) Citation

Shariati, Aref, Masoud Dadashi, Zahra Chegini, Alex van Belkum, Mehdi Mirzaii, Seyed Sajjad Khoramrooz, and Davood Darban-Sarokhalil. "The Global Prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus Aureus and Coagulase–negative Staphylococci Strains: A Systematic Review and Meta-analysis." Antimicrobial Resistance & Infection Control 9, no. 1 (2020): 56-20. https://doi.org/10.1186/s13756-020-00714-9.

MLA (9th ed.) Citation

Shariati, Aref, et al. "The Global Prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus Aureus and Coagulase–negative Staphylococci Strains: A Systematic Review and Meta-analysis." Antimicrobial Resistance & Infection Control, vol. 9, no. 1, 2020, pp. 56-20, https://doi.org/10.1186/s13756-020-00714-9.